Pioglitazone was given as a 30-mg tablet once daily (Actos). Meals were served three times daily, at 8:00 A.M., 12:00 P.M., and 5:30 P.M.

Conclusions: GLP-1 and pioglitazone show an additive glucose-lowering effect. A combination of the two agents may, therefore, be a valuable therapeutic approach for the treatment of type 2 diabetes.

Pioglitazone is known to improve insulin sensitivity, glycaemic control, hypertension, dyslipidaemia and microalbuminuria in patients with diabetes mellitus. 5 Furthermore, a prior meta-analysis found ...

The Subject Expert Committee (SEC) for Endocrinology & Metabolism under the Central Drugs Standard Control Organisation ...

(RTTNews) - Amneal Pharmaceutical LLC, a unit of Amneal Pharmaceuticals, Inc., is recalling three lots of Sulfamethoxazole and Trimethoprim Tablets, USP, 400 mg/80 mg, to the consumer level due to ...